Pence signs bill expanding use of overdose drug
The new law allows Indiana residents to obtain and use a drug that can reverse heroin overdoses in their relatives, friends and loved ones.
Pharmaceutical
Articles
U.S. prescription drug spending jumps 13 percent
U.S. spending on prescription drugs soared last year, driven up primarily by costly breakthrough medicines, manufacturer price hikes and a surge from millions of people newly insured due to the Affordable Care Act.
Right-to-try drug bill signed into state law
Terminally ill patients in Indiana who have run out of FDA-approved options can now turn to treatments and medicines in the testing phase.
Potential Alzheimer’s drug further backs protein hypothesis
The results of an experimental drug for Alzheimer’s disease provide the best evidence so far that the memory-robbing condition is caused by an errant protein in the brain. Drugmakers including Eli Lilly have been concentrating their Alzheimer’s research on that area.
‘Right to try’ trial drugs bill heads to governor’s desk
A proposal to give terminally ill patients easier access to experimental drugs not yet on pharmacy shelves has been forwarded to Gov. Mike Pence for his signature.
Indiana Senate passes ‘right-to-try’ trial drugs bill
The Indiana Senate has approved a measure that would allow terminally ill patients to use experimental drugs that are not yet on pharmacy shelves.
Senate panel considers ‘right-to-try’ trial drugs bill
An Indiana Senate committee is considering a bill that would give terminally ill patients easier access to experimental drugs that have not received full federal approval. Indiana is one of nearly two dozen states that are considering the legislation.
Warnings ordered on testosterone drugs like Lilly’s Axiron
Makers of testosterone drugs must change the products’ labels to clarify that they are approved for only certain disorders, not to help men deal with aging, U.S. regulators said.
Bill aimed at reducing meth problems advances
The Indiana Senate passed a bill 46-3 on Tuesday that would make it more difficult for criminals to purchase products used in the production of meth.
Lilly to delay U.S., EU approval of basal insulin
Although the experimental diabetes drug is in final-stage testing and showing promising results, Lilly wants to better understand its effect on liver fat.
Feds finally end probe into Lilly bribery allegations
The U.S. Department of Justice told Lilly last month its investigation was over—more than a year after the drugmaker paid $29 million to the SEC to settle related bribery allegations.
Lawmakers aim to restrict access to meth ingredients
The leaders of Indiana communities hit hard by methamphetamine are arguing for a state law requiring prescriptions to buy cold and allergy pills.
How Eli Lilly CEO Lechleiter pulled company out of long slide
After weathering a barrage of patent expirations, the pharmaceutical giant has restocked its pipeline and is positioned to grow.
Medical-marijuana bill won’t fly this session, but attitudes shift
Indiana won’t put itself on the marijuana-friendly map this year, as a medical marijuana bill authored by Democratic Sen. Karen Tallian is unlikely to go further than a committee hearing.
Novartis expects price war with Lilly over psoriasis drugs
Novartis AG is racing to establish itself in the market for new treatments for psoriasis ahead of competing drugs by Amgen Inc. and Eli Lilly and Co. in the United States.
UPDATE: Lilly says it couldn’t have made tainted Cialis
A batch of Cialis pills, purportedly made at a plant in Australia, was banned by the FDA from entering the U.S. after the pills were found to contain the active ingredient for rival drug Viagra. Cialis manufacturer Eli Lilly said it doesn’t make any drugs in Australia.
Lilly’s Cyramza gets new marketing approval
Eli Lilly and Co.'s drug Cyramza has been approved as a treatment for lung cancer, regulators said. The Food and Drug Administration is allowing Lilly to market the drug as a treatment for cases that have spread.
Alzheimer’s tests present dilemma of knowing the future
While the tests will likely help drug companies like Eli Lilly and Co. evaluate medicines, they’ll also create wrenching personal and ethical dilemmas for patients who will have to live with the knowledge that they’re destined to develop the disease.
Lilly rheumatoid arthritis drug meets goals in final-stage trial
If approved, Baricitinib may bring Lilly $673 million in 2020, according to the average of five analysts’ estimates compiled by Bloomberg.
Lilly competitor claims early success with Alzheimer’s drug
Biogen Idec Inc. shares rose Tuesday after the company said its Alzheimer’s drug showed promising early results and will be quickly moved into a final-stage trial.